Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Dental Corporation Public Company Limited (D.BK)
Bangkok, BKK, TH
Dental Corporation Public Company Limited, together with its subsidiaries, provides dental services in Thailand. The company offers dental diagnosis and general dentistry, dental implants, oral surgery, and root canal treatment, as well as cosmetic, periodontic, prosthodontic, and orthodontic dentistry services. It also provides dental laboratory services; and distributes dental supplies and equipment. The company was founded in 2005 and is headquartered in Bangkok, Thailand.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -1.42% | -2.80% | -9.74% | +11.20% | +13.01% | +27.52% | -61.92% | -20.80% | -31.53% | -31.53% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+9.7% Q1'26: +17.4% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+66.7% ★ Q1'26: +39.9% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+9.7% ★ Q1'26: +11.7% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+11.8% ★ Q1'26: +11.0% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+8.8% ★ Q1'26: +9.1% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.90× Q1'26: 1.91× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
459.63M
est: 448.00M (+2.6%)
|
643.19M
est: 448.00M (+43.6%)
|
772.81M
est: 660.00M (+17.1%)
|
572.41M
est: 1.07B (-46.7%)
|
528.51M
est: 1.17B (-54.8%)
|
927.29M
est: 934.00M (-0.7%)
|
954.38M
est: 965.00M (-1.1%)
|
1.05B
est: 1.03B (+1.4%)
|
1.20B
1.20B – 1.20B
+16.6% YoY
|
1.37B
1.37B – 1.37B
+14.1% YoY
|
| EBITDA |
73.34M
est: 50.48M (+45.3%)
|
84.94M
est: 50.48M (+68.2%)
|
41.22M
est: 74.37M (-44.6%)
|
45.44M
est: 120.91M (-62.4%)
|
26.05M
est: 131.84M (-80.2%)
|
147.29M
est: 105.25M (+39.9%)
|
121.84M
est: 238.24M (-48.9%)
|
166.33M
est: 255.03M (-34.8%)
|
297.25M
297.25M – 297.25M
+16.6% YoY
|
339.22M
339.22M – 339.22M
+14.1% YoY
|
| EBIT |
56.19M
est: 26.71M (+110.4%)
|
50.16M
est: 26.71M (+87.8%)
|
4.12M
est: 39.35M (-89.5%)
|
6.50M
est: 63.97M (-89.8%)
|
-9.76M
est: 69.75M (-114.0%)
|
108.72M
est: 55.68M (+95.3%)
|
81.09M
est: 221.16M (-63.3%)
|
123.92M
est: 236.75M (-47.7%)
|
275.94M
275.94M – 275.94M
+16.6% YoY
|
314.90M
314.90M – 314.90M
+14.1% YoY
|
| Net Income |
46.11M
est: 55.54M (-17.0%)
|
33.46M
est: 55.54M (-39.8%)
|
-15.59M
est: 71.74M (-121.7%)
|
-7.80M
est: 99.51M (-107.8%)
|
-24.23M
est: 122.66M (-119.8%)
|
71.25M
est: 82.13M (-13.2%)
|
50.47M
est: 59.88M (-15.7%)
|
85.77M
est: 71.86M (+19.4%)
|
95.81M
95.81M – 95.81M
+33.3% YoY
|
109.50M
109.50M – 109.50M
+14.3% YoY
|
| SGA |
120.82M
est: 118.35M (+2.1%)
|
163.39M
est: 118.35M (+38.1%)
|
223.85M
est: 174.35M (+28.4%)
|
166.91M
est: 283.45M (-41.1%)
|
152.13M
est: 309.08M (-50.8%)
|
223.26M
est: 246.73M (-9.5%)
|
246.25M
est: 247.57M (-0.5%)
|
265.42M
est: 265.02M (+0.2%)
|
308.89M
308.89M – 308.89M
+16.6% YoY
|
352.50M
352.50M – 352.50M
+14.1% YoY
|
| EPS |
0.17
est: 0.16 (+4.7%)
|
0.12
est: 0.16 (-26.1%)
|
-0.06
est: 0.21 (-127.3%)
|
-0.02
est: 0.29 (-108.3%)
|
-0.07
est: 0.36 (-120.7%)
|
0.21
est: 0.24 (-12.5%)
|
0.15
est: 0.18 (-14.3%)
|
0.25
est: 0.21 (+19.0%)
|
0.28
0.28 – 0.28
+33.3% YoY
|
0.32
0.32 – 0.32
+14.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Natha Ratanalert | President & Independent Chairman of the Board | 93.0K | female |
| Pornsak Tantapakul | CEO & Vice Chairman | 56.0K | male |
| Kanlaya Thongjerm | Accounting Manager | — | female |
| Nattasit Surapanpairoj | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for D.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
